MedPath

RIVA-OXYBUTYNIN

RIVA-OXYBUTYNIN

Approved
DIN Number

02299364

Drug Class

Human

Market Date

Jun 9, 2008

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02299364
AIG Number0114692001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD04 OXYBUTYNIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification86:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

OXYBUTYNIN CHLORIDEActive
Strength: 5 MG
Monograph: OXYBUTYNIN CHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.